In conclusion, our analysis is the first comprehensive cost-effectiveness simulation to compare multiple prevention and risk-stratification strategies for the primary prevention of CHD including treating the entire at-risk population with statins, utilizing CAC-based approaches including the SHAPE guidelines, applying CRP-based approaches such as in the JUPITER trial, following the ATP III guidelines, and implementing the ACC/AHA lipid guidelines. Here, CRP is linked to coronary artery disorder.